Frank Perier joined SpringWorks Therapeutics in 2019. He has more than 25 years of experience leading finance organizations in the pharmaceutical industry. Previously, Frank was the Chief Financial Officer at Forest Laboratories, Inc. for 10 years before the company’s acquisition by Actavis. Before joining Forest, Frank was with Bristol-Myers Squibb for approximately nine years, where he worked in corporate and operations finance capacities of increasing responsibilities, including Vice President of Finance and Operations Planning-Americas Medicines Group, the company’s largest business unit at that time. Before joining Bristol-Myers Squibb, he was an accounting and auditing partner at Deloitte, where he worked for about 15 years. Frank was a member of the Board of Directors of Concordia International, Inc., a specialty pharmaceutical company, until September 2018 where he served on the Audit and the Human Resources and Compensation Committees of the Company. Frank received a B.S. in accountancy from Villanova University and an MBA from the Stern School of Business, New York University. He is a Certified Public Accountant (inactive) and a member of the New Jersey Society of Certified Public Accountants and the American Institute of Certified Public Accountants.